All News

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Senator Bill Cassidy, R-Louisiana, is working with Democratic colleagues Michael Bennet of Colorado and Maggie Hassan of New Hampshire to introduce a bill this month to stop patients from getting surprise medical bills; the FDA warned a major Canadian drug distributor, CanaRx to stop selling unapproved and mislabeled medicines to Americans looking to save money on prescriptions; Democratic leaders in the House of Representatives are trying to keep the chamber united behind narrower proposals aimed at strengthening the Affordable Care Act and lowering drug prices in the wake of the introduction of a Medicare for All bill.

The vast majority of patients with COPD require greater motivation to seek help when symptom changes occur and are unaware of their increased risk of developing lung cancer, according to new research.

AstraZeneca and Merck will present full results at a future meeting; Myriad Genetics will file a supplemental application for its companion diagnostic.

How to improve patient-reported measurement in oncology valued-based care is the focus of a new report from The National Pharmaceutical Council and Discern Health.

Here are 5 interesting findings from the February 2019 issue of AJMC®.

Between 2014 and 2017, antivirals were consistently the number 1 most costly outpatient drug group for Medicaid, and HIV antiretrovirals and hepatitis C drugs accounted for more than 90% of spending on these antivirals.

A webinar presented by the Patient-Centered Primary Care Collaborative emphasized the issues that women continue to face regarding fairness and equality in modern healthcare, discussing topics such as caregiving, maternal and mental health, racial disparities, and more.

A new study determines the smallest change in upper extremity function that patients with multiple sclerosis (MS) find important or meaningful through an analysis in the change of scores of the Arm Functiom in Multiple Sclerosis Questionnaire.

Here are the top 5 articles for the month of February.

During the hearing on drug pricing held yesterday before the US Senate Committee on Finance, 7 pharmaceutical executives gave testimony in an effort to explain rising drug costs in the United States and offer solutions to lower them.

According to a new study, migraine is associated with a higher risk of open-angle glaucoma compared with patients with no migraine.

House Democrats are expected to introduce a Medicare for All bill today; CMS' Center for Medicare and Medicaid Innovation is planning to unveil a new payment model for primary care physicians; and CMS, CDC, and FDA have established a task force to improve future responses to public health emergencies.

Areas such as physical health showed improvement, but career and social well-being continue to weaken for Americans.

Patients with metastatic castration-resistant prostate cancer (mCRPC) have a lower risk of developing grade 3 or 4 neutropenia, likely due to less exposure to docetaxel.

Hospitals nationwide continued to snap up medical practices, according to updated figures about acquisition trends and the impact on physician employment.

Both travel and wait times for healthcare services are longest when compared with other services, such as getting a license or a vehicle repaired.

A high proportion of patients with acute myeloid leukemia (AML) who achieve a negative minimal residual disease (MRD) status still relapse, indicating a more sensitive method of detecting MRD is needed.

New Mexico, Colorado, Oregon, Washington, and Minnesota are among states looking at “Medicaid buy-in” proposals as a way to offer more affordable healthcare options; the return of measles is creating a backlash against critics of vaccines; first responders who worked during and after the 9/11 terror attacks and their advocates urged Congress to ensure that the September 11th Victim Compensation Fund does not run out of money.

The study followed a directive from CMS to screen dialysis patients for depression and develop a follow-up plan for care for those diagnosed.

Research from 2008 to 2014 suggests that vaccinations have been successful in preventing the most dangerous strains of HPV that cause nearly 70% of cervical cancer.

The grilling that pharmaceutical company executives are expected to face Tuesday before the Senate Finance Committee is reminiscent of previous hearings with businesses that proved to be turning points; UnitedHealthcare lost its case to prevent a former executive from working at the new healthcare venture formed by Amazon, Berkshire Hathaway, and JPMorgan Chase; a bill to establish work requirements for thousands of Medicaid recipients in Wyoming passed its first reading in the state’s House.

There is no significant evidence to suggest that acute exacerbations of chronic obstructive pulmonary disease (COPD) cause an overall decline in patients’ physical activity over time, according to a new longitudinal study.

A group of researchers systematically reviewed previously published literature about psychological treatment in primary headache and its effectiveness. The results were published in The Journal of Headache and Pain.

A case series discusses how a liver biopsy may prove instrumental in determining if ruxolitinib therapy should be discontinued or continued in patients with myelofibrosis (MF) and polycythemia vera (PV) experiencing liver damage.

The only curative treatment for myelofibrosis (MF) continues to be allogeneic hematopoietic stem cell transplant (HSCT). Occasionally, adverse events posttransplantation can occur and usually present within the first 2 years after posttransplant. Researchers recently sought to analyze the outcome of 2-year disease-free survivors in a systematic review published in Haematologica.

While rates of physician burnout decreased between 2014 and 2017, burnout remains higher among physicians than among other fields.

The rule takes effect in 60 days, but the provision requiring physical separation of facilities that perform abortion takes effect in a year.